CONMED CORPORATION Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, before Tax
CONMED CORPORATION (CNMD) reported Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, before Tax of -$4.74 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-24.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax · last filed 2020-02-24
- CONMED CORPORATION other comprehensive income (loss), derivatives qualifying as hedges, before tax for fiscal 2019 was -$4.74M, a 143.11% decline from fiscal 2018.
- CONMED CORPORATION other comprehensive income (loss), derivatives qualifying as hedges, before tax for fiscal 2018 was $10.98M.
- CONMED CORPORATION other comprehensive income (loss), derivatives qualifying as hedges, before tax for fiscal 2017 was -$8.05M, a 1571.85% decline from fiscal 2016.
- CONMED CORPORATION other comprehensive income (loss), derivatives qualifying as hedges, before tax for fiscal 2016 was $547.00K.
| Period end | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, before Tax 12 month |
|---|---|
| 2019-12-31 | -$4.74M 10-K · filed 2020-02-24 |
| 2018-12-31 | $10.98M 10-K · filed 2020-02-24 |
| 2017-12-31 | -$8.05M 10-K · filed 2020-02-24 |
| 2016-12-31 | $547.00K 10-K · filed 2019-02-25 |
| 2015-12-31 | -$3.29M 10-K · filed 2018-02-26 |
| 2014-12-31 | $7.39M 10-K · filed 2017-02-27 |
| 2013-12-31 | -$404.00K 10-K · filed 2016-02-23 |
| 2012-12-31 | -$6.51M 10-K · filed 2015-02-23 |
| 2011-12-31 | $6.69M 10-K · filed 2014-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |